FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075136 [Registered on: 11/10/2024] Trial Registered Prospectively
Last Modified On: 11/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of two different techniques of spinal anaesthesia in pregnant patients undergoing cesarean section 
Scientific Title of Study   Comparison of Sequential spinal anesthesia technique v/s Premixed bolus dose of Inj. Hyperbaric Levobupivacaine (0.5 percentage) with Inj. Fentanyl (25 ug) for patients undergoing cesarean section surgery: A Randomized Controlled Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Javia Fenil Ileshkumar 
Designation  Resident doctor (M.D. Anaesthesiology) 
Affiliation  GMERS medical college, Gotri, Vadodara 
Address  6th floor, Department of Anaesthesiology, GMERS Medical College, Gotri, Vadodara

Vadodara
GUJARAT
390021
India 
Phone  9409530330  
Fax    
Email  feniljavia@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Santosh Dubey 
Designation  Associate professor 
Affiliation  GMERS medical college, Gotri, Vadodara 
Address  Dr Santosh Dubey Flat no. G3, Riddhi Siddhi flat, near gotri water tank,Gotri, Vadodara
6th floor, Department of Anaesthesiology, GMERS Medical College, Gotri, Vadodara
Vadodara
GUJARAT
390021
India 
Phone  9825359853  
Fax    
Email  santosh19692001@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Santosh Dubey 
Designation  Associate professor 
Affiliation  GMERS medical college, Gotri, Vadodara 
Address  Dr Santosh Dubey Flat no. G3, Riddhi Siddhi flat, near gotri water tank,Gotri, Vadodara
6th floor, Department of Anaesthesiology, GMERS Medical College, Gotri, Vadodara
Vadodara
GUJARAT
390021
India 
Phone  9825359853  
Fax    
Email  santosh19692001@yahoo.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  GMERS Hospital 
Address  Old TB hospital campus, gotri main road, gotri, Vadodara-390021, Gujarat, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Fenil Javia  GMERS hospital  Anaesthesia department,6th floor, Old TB hospital campus, gotri, Vadodara
Vadodara
GUJARAT 
9409530330

feniljavia@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IHEC GMERS medical college and hospital, Gotri  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 1||Obstetrics,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Premixed bolus dose with inj Fentanyl mixed with inj Levobupivacaine  Under all aseptic & antiseptic precautions spinal anaesthesia will be given in L3–L4 intervertebral space in sitting position in all cases. 23G Quincke’s Spinal needle will be inserted. After confirmation of free CSF flow, with the bevel of the needle pointing upwards, drug will be injected intrathecally. In this method, Inj. Levobupivacaine 0.5% 1.5 ml and Inj. Fentanyl 25 mcg 0.5ml will be mixed and bolus injection given.  
Intervention  Sequential spinal anaesthesia with inj Fentanyl immediately followed by inj Levobupivacaine  Under all aseptic & antiseptic precautions spinal anaesthesia will be given in L3–L4 intervertebral space in sitting position in all cases. 23G Quincke’s spinal needle will be inserted. After confirmation of free CSF flow, with the bevel of the needle pointing upwards, drug will be injected intrathecally. In this method, Inj. Fentanyl 25mcg 0.5 ml taken in a 2cc syringe will be injected first immediately followed by Inj. Levobupivacaine 0.5% 1.5 ml taken in a 5cc syringe without aspiration.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Weight –50-80kgs
Height – 150-170cm
Parturients with singleton pregnancy
ASA-2
 
 
ExclusionCriteria 
Details  Patient with absolute & relative contraindications of spinal anaesthesia
Allergy to Local anaesthetics
Parturient with multiple pregnancy (twin pregnancy or triplet)
Patient’s refusal to take part in study
Pregnancy with eclampsia or preeclampsia
Pregnancy with Abruptio placenta , placenta previa, placenta accreta, placenta percreta or placenta increta etc
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Difference in time to achieve highest level of sensory block in both the groups  1 minute, 2 minutes, 3 minutes, 4 minutes,5 minutes till adequate sensory level is achieved after spinal anaesthesia 
 
Secondary Outcome  
Outcome  TimePoints 
•Time to achieve motor blockade
•Comparision of hemodynamic stability
•Duration of analgesia
•To observe any complication(Bradycardia, Hypotension, Shivering, Nausea, Vomiting, Pruritus, Urinary retention)  
•Time to achieve motor blockade (at 1 minute, 2 minutes, 3 minutes, 4 minutes,5 minutes & so on after spinal anaesthesia)
•Comparision of hemodynamic stability (at 1 minute, 3 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes & 1 hour after spinal anaesthesia)
•Duration of analgesia (at 1 hour, 3 hours, 6 hours & 12 hours after completion of surgery)
•To observe any complication(Bradycardia, Hypotension, Shivering, Nausea, Vomiting, Pruritus, Urinary retention)  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIM

Comparison of block characteristics between sequential spinal anaesthesia technique and bolus dose of spinal anaesthesia technique in the patients of cesarean section surgery under spinal anaesthesia.

 

 

OBJECTIVES:

PRIMARY OBJECTIVE:

·                Time to achieve level of sensory blockade(T6) (mins)

SECONDARY OBJECTIVES:

·                Time to achieve motor blockade

·                Hemodynamic stability

·                Duration of analgesia

·                To observe any complication (Bradycardia, Hypotension, Shivering, Nausea, Vomiting, Pruritus, Urinary retention)

 

METHODOLOGY:

Ethical consideration- The principles of Helsinki declaration will be followed throughout the study. This study will be conducted after getting approval from local ethical committee of GMERS medical college and Hospital, Gotri, Vadodara. It will be registered with clinical trial registry of India. Written and Informed consent will be taken from all participants. Data collected will be kept confidential.

Study design-      Randomized controlled study, Double blind, parallel group

Study setting- Tertiary care teaching hospital (GMERS Medical college and Hospital), Gotri, Vadodara.

Study duration- Approx. 6 months

Study population- Patients posted for open unilateral inguinal hernia surgery.

 

 

 

 

INCLUSION CRITERIA:

1.                   Age-18 to 40 years of age

2.                   Weight –50-80kgs

3.                   Height – 150-170cm

4.                   Parturients with singleton pregnancy

5.                   ASA-2

 

EXCLUSION CRITERIA:

1.                   Patient with absolute & relative contraindications of spinal anaesthesia

2.                   Allergy to Local anaesthetics

3.                   Parturient with multiple pregnancy (twin pregnancy or triplet)

4.                   Patient’s refusal to take part in study

5.                   Pregnancy with eclampsia or preeclampsia

6.                   Pregnancy with Abruptio placenta , placenta previa, placenta accreta, placenta percreta or placenta increta etc.

 

Study procedure:

Randomization and allocation: Patients will be randomly divided into two groups by simple randomization (single block) 1:1 uniform allocation. Randomization and allocation will be conducted by an independent person, not involved in the study. The sequential random numbers assigned to study participants will be kept in sealed opaque envelops, to be opened after recruitment of the participants in the study, just before giving the spinal anaesthesia. The groups are as follows:

 

 

Group B:

 Inj. Levobupivacaine 0.5% 1.5 ml+ Inj. Fentanyl 25mcg 0.5ml (the drug will be taken in a 5cc syringe)

Group S:

Inj. Fentanyl 25mcg 0.5ml followed by Inj. Levobupivacaine 0.5% 1.5 ml (the drugs will be taken in two separate syringes-2 cc & 5 cc respectively)

 

INTERVENTION:

Pre-operative assessment and selection of Patients: A thorough pre-operative assessment of the patients of caesarean section surgery under spinal anaesthesia will be carried out and the details will be recorded in the proforma. History will be taken regarding present and past complaints, personal history, medication history, history of previous anaesthesia exposure, blood transfusions, jaundice etc. General and systemic examination will be done. Routine and specific investigations will be carried out as and when indicated.After securing 18 G or 20G intra venous line, intravenous fluid (Inj. RL) will be started.

 

SEQUENTIAL SPINAL ANESTHESIA TECHNIQUE

Under all aseptic & antiseptic precautions spinal anaesthesia will be given in L3–L4 intervertebral space in sitting position in all cases. 23G Quincke’s spinal needle will be inserted. After confirmation of free CSF flow, with the bevel of the needle pointing upwards, drug will be injected  intrathecally.

In this method, Inj. Fentanyl 25mcg 0.5 ml taken in a 2cc syringe will be injected first immediately followed by Inj. Levobupivacaine 0.5% 1.5 ml taken in a 5cc syringe without aspiration.

Inj PARACETAMOL will be given 15 mins before completion of procedure in both the groups

 

 

BOLUS DOSE OF SPINAL ANESTHESIA TECHNIQUE

Under all aseptic & antiseptic precautions spinal anaesthesia will be given in L3–L4 intervertebral space in sitting position in all cases. 23G Quincke’s Spinal needle will be inserted. After confirmation of free CSF flow, with the bevel of the needle pointing upwards, drug will be injected intrathecally.

In this method, Inj. Levobupivacaine 0.5% 1.5 ml and Inj. Fentanyl 25 mcg 0.5ml will be mixed and bolus injection given.

 

DATA COLLECTION:

Sensory block (by pin prick method) will be assessed every 15 sec for 2min and then every min for 10 min after completion of intrathecal injection of the drug.

Time to achieve sensory level (time interval between complete subarachnoid drug injection to onset of complete loss of pinprick sensation at sensory level T8) in mins.

Motor block will be assessed with the help of bromage scale (ask the patient to raise her leg without bending from the knee) after complete subarachnoid drug injection.

Hemodynamic parameters will be assessed immediately after complete subarachnoid drug injection, at 3 mins, 5 mins, 10 mins, 15 mins, 20 mins, 30 mins, 45 mins and 1 hour after complete subarachnoid drug injection.

OUTCOME MEASURES:

Primary outcome-

·                Difference in time to achieve level of sensory block in both the groups.

Secondary outcomes-

·                Characteristic of motor blockade

·                Comparison of Hemodynamic stability

·                Duration of analgesia

·                Look for any complications


 

 
Close